Patient P-01804

Synthetic patientNBL-101 · Day 111 · 55–64 · F · baseline S19Steering view · 3D Open companion preview

Therapy response

Favorable

Tolerance

Deteriorating

GI state

Deteriorating

Inflammatory state

Favorable

Nutritional resilience

Declining

Discontinuation risk

32%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events

solid = observed · dashed = predicted

Day 0 NBL-101 started — Baseline state S19
Day 26 AD-05 recommended — Adherence Support AD-05
Day 27 Patient accepted — Started AD-05 in the companion
Day 32 GI symptom burden −19% vs expected — Adherence Support AD-05
Day 38 Tolerance state changed — Unstable → Improving

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days

GI instability+10
Toxicity+9
Nutritional resilience-7
Inflammatory activity+2

What helped?

Adherence Support AD-05Day 26
Result: symptom burden −19%

LIFE OS recommendation

No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

GI burden

Companion

26.8/100

stable · +0.4 vs previous 14 d

Toxicity

Blood

27/100

stable · +0.4 vs previous 14 d

Sleep quality

Wearable

22.7/100

worsening · -7.1 vs previous 14 d

Energy level

Daily log

5/10

stable · -0.2 vs previous 14 d

Stress level

Daily log

5.4/10

stable · +0.1 vs previous 14 d

Steps

Wearable

4,947

worsening · -273 vs previous 14 d

Adherence

Companion

96 %

stable · -1.8 vs previous 14 d

This trajectory is decaying — what would help, what would not

Steering view →

Heading towards failing · 68 from the failing basin, 20 from restoration.

Would help

No untried action with strong evidence. Compose one from primitives.

Would not help

Nothing clearly counter-productive in the record.

State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

Insoluble fibre
+1.6no signal · 38%
Histamine load
+1no signal · 25%
Simple carbohydrates
-0.5no signal · 15%
Alcohol
+0.5no signal · 15%
Spicy / capsaicin
+0.4no signal · 15%
Dietary fat load
+0.3no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure

Autonomic recovery ↓45
- WearableResting HR 77 bpm
- WearableShort sleep window
Inflammatory signalling ↑35
- MicrobiomeBacteroides fragilis expansion
- WearableHRV 26 ms, trending down
Mucosal barrier integrity ↓10
- WearableSleep 6.1 h, below personal baseline

DNA

Fictional pharmacogenomic panel

CYP2D6 Rapid metabolizer
Expected exposure
MTHFR C677T
Reduced folate turnover

Microbiome

Shannon diversity 4.4 · butyrate capacity 60/100

Akkermansia muciniphilaNormal
Faecalibacterium prausnitziiNormal
Bacteroides fragilisHigh
Bifidobacterium longumNormal
EnterobacteriaceaeHigh

Wearable, last 14 days

daily evolution fed into the runtime

HRV: 30 ms
Sleep: 6.2 h
Steps: 4,752
Resting HR: 74 bpm

Daily log: GI score 27, nutritional resilience 60, adherence 96.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview

What to eat

Keep meals regular; three to four moderate portions spaced through the day
Include a cooked vegetable portion with each main meal
Keep fibre steady; no new sources this week
Avoid known triggers for now: fried or oily food, dairy, alcohol

What to do

Log the daily check-in; one line is enough
A 15-minute walk after lunch
Protect a 7.5-hour sleep window; screens off 30 minutes before
Keep hydration steady: small amounts through the day rather than large volumes at once

What to take

Take the scheduled dose as agreed with your care team
No additional supplements this week
Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Patient	Similarity	Baseline	Intervention	Outcome	Response today
P-01541	32%	S09	AD-05	no change	43
P-01377	30%	S11	AD-05	no change	42
P-01483	29%	S14	AD-05	no change	35
P-01679	29%	S12	AD-05	no change	39
P-01350	31%	S19	BR-03	no change	34
P-01689	31%	S13	BR-03	no change	50
P-01329	30%	S08	BR-03	improved	79
P-01495	28%	S07	BR-03	improved	85
P-01313	27%	S01	BR-03	improved	32
P-01468	27%	S06	BR-03	no change	41
P-01430	45%	S05	CR-01	improved	54
P-01442	28%	S13	CR-01	improved	61